Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Rheumatology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Rheumatology Other
    Severe Joint Pain in Multiple Areas Associated With Increased Risk of Falls in Older Adults - (DGNews)
    Rilonacept Approved in the EU for Cryopyrin-Associated Periodic Syndromes - (DGNews)
    Canakinumab Gives Faster, Greater Pain Relief in Refractory Gout Patients: Presented at ACR/ARHP - (DGDispatch)
    Previous Urate-Lowering Therapy Plus Febuxostat Lowers Urate Levels, Number of Flares in Patients With Gout: Presented at ACR/ARHP - (DGDispatch)
    Low-Dose Colchicine Eases Pain Due to Acute Gout Flare: Presented at ACR/ARHP - (DGDispatch)

    News archive

     Recent webcasts/CME - Rheumatology Other
    Biologics and Infections: Common and Rare

    Webcasts/CME archive

     Recent cases - Rheumatology Other
      Pigmented Villonodular Synovitis of the Knee in a Patient on Oral Anticoagulation Therapy: A Case Report
      Rectal Mucosal Prolapse Syndrome as an Unusual Gastrointestinal Manifestation of Sjogren's Syndrome: A Case Report
      HELLP Syndrome, Multiple Liver Infarctions, and Intrauterine Fetal Death in a Patient with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
      Nasal Septal Perforation in a Patient with Takayasu's Arteritis; a Rare Association
      Nummular Keratopathy in a Patient with Hyper-IgD Syndrome

      Cases archive
        




      my personal edition > rheumatology other > news
      divider

        E-Mail this DGReview to a colleague

      DGReview


      Statins may play a role in the treatment of inflammatory rheumatic diseases

      A DGReview of :"Therapy with statins in patients with refractory rheumatic diseases: a preliminary study"
      Lupus

      09/28/2003
      By Mary Beth Nierengarten


      Results from a preliminary study indicate patients with inflammatory rheumatic diseases might benefit from treatment with statin agents, reports a study from Mexico.

      Although statins are widely used to treat ischaemic coronary disease, as well as to control hypercholesterolaemia, their use for inflammatory diseases is less evident, despite biochemical data that show their inhibitory effects on many processes involved in inflammatory diseases.

      To evaluate the therapeutic potential of statins to treat different inflammatory rheumatic diseases that are refractory to conventional therapy, Carlos Abud-Mendoza, MD, and colleagues from Hospital Central, San Luis Potosi, Mexico, conducted a preliminary, short-term, open clinical trial to examine the effect of simvastatin 80 mg once daily or atorvastatin 20 mg once daily in 10 patients with inflammatory rheumatic diseases that was refractory to conventional therapy.

      Of the 10 patients, 5 received simvastatin for systemic lupus erythematosus (SLE); three were refractory to high doses of prednisone and cyclophosphamide and azathioprine or methotrexate; two with systemic vasculitis that was refractory to high doses of prednisone and cytotoxic drugs or prednisone, cyclophosphamide, azathioprine, and etanercept. The other five patients received atorvastatin for rheumatoid arthritis (RA) that was refractory to methotrexate, sulfasalazine, azathioprine, and/or leflunomide and prednisone.

      Preliminary results of the first study showed that the administration of simvastatin for 8 days was associated with a rapid and significant reduction in proteinuria levels in the three patients with SLE, as well as in the 2 patients with systemic vasculitis. In the five patients with RA, atorvastatin for 8 days was associated with a reduction in C-reactive protein levels and clinical improvement.

      There was a significant reduction in spontaneous apoptosis of peripheral blood lymphocytes and expression of CD69 and human leukocyte antigen (HLA-DR) in the SLE patients treated with simvastatin. To compare the effect of short-term simvastatin versus chloroquine, the authors conducted a separate study of 15 RA patients who failed to achieve a satisfactory response after treatment with methotrexate and prednisone.

      Ten patients received short-term simvastatin 40 mg/day and five received chloroquine 250 mg/day.

      Preliminary results of this study showed an improved clinical response in 90% of the patients treated with simvastatin after 8 weeks, but no similar response was seen in the any of the patients treated with chloroquine.

      Based on these results, the authors conclude that statins may have an important therapeutic potential for different inflammatory diseases, and that controlled trials are necessary to further test their benefit in the treatment of these diseases.
      Lupus 2003;12:8:607-611. "Therapy with statins in patients with refractory rheumatic diseases: a preliminary study"

      E-Mail this DGReview to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send